Latest News

February 20, 2014 03:29 PM
Benefit of Bevacizumab in Glioblastoma Under Discussion

An in-depth update from Medscape on the debate surrounding the use of Avastin in treating GBM.  ABC2's petitioning of the FDA is noted.

January 31, 2014 05:22 PM
When Will Genomics Cure Cancer?

An interview with biogeneticist Eric S. Lander in the January/February issue of The Atlantic.

January 22, 2014 09:32 AM
OncoSynergy, Fighting Brain Cancer as the Family Business

Dr. Shawn Carbonell is OncoSynergy's CEO and his wife, Dr. Anne-Marie Carbonell, is the VP of Clinical Development.  OncoSynergy is the Social Media Sponsor of the 2014 Race for Hope DC.

December 23, 2013 11:14 AM
ABC2-Funded Research on Glioma Genomics Featured in Science

Recurrent Brain Cancers Follow Distinctive Genetic Paths, UCSF Team Shows Commonly Used Brain Tumor Chemotherapy Agent May Propel Recurrent Tumors to Malignancy

December 20, 2013 02:14 PM
See the Miami HEAT vs. the Boston Celtics and support the Florida Brain Cancer 5k!

Enjoy discounted seats at the Miami HEAT game on January 21st and support brain cancer research.

December 10, 2013 04:40 PM
UF researcher receives more than $500,000 for pediatric brain tumor research

The latest update on the UF pediatric research project funded by Accelerate Brain Cancer Cure, Paul Hale and the Florida Brain Tumor Association.

November 21, 2013 11:15 AM
Why I Went "Over The Edge" For Brain Cancer Research

Cara  Perellis, Project Manager at the Case Foundation, shares why she took a 365 foot plunge off the tallest building in San Diego!

November 15, 2013 11:34 AM
7th Annual Bruce A. Rendina Memorial Golf Tournament

The proceeds of the charity tournament support Accelerate Brain Cancer Cure's collaborative research funding at University of Florida.

November 4, 2013 10:56 AM
Thanks To Our Race Towards A Cure Marine Corps Marathon and MCM10k Team!

With the support of many friends, co-workers and family, our team has raised over $59,000 for brain tumor research.

October 29, 2013 04:31 PM
ABC2 Collaboration Fuels New Pediatric Vaccine Trial at University of Florida

The Phase II trial is led by Dr. Duane Mitchell, director of the UF Brain Tumor Immunotherapy Program.

October 21, 2013 01:45 PM
Max Wallace Talks Innovation at Congress of Neurological Surgeons Annual Meeting

Key industry and foundation leaders were invited to share their disruptive ideas on the future of neurosurgery at the new CNS Neurosurgery Innovations Symposium.

October 15, 2013 04:37 PM
NCI/ABC2 Co-host Groundbreaking Clinical Trials Conference

A letter to the brain tumor community from Max Wallace, CEO of Accelerate Brain Cancer Cure.

October 14, 2013 12:50 PM
Breaking Through Cancer's Shield

The NCI/ABC2 meeting in September discussed how a powerful new class of immunotherapy drugs--PD-1 inhibitors--might be used to treat glioma. This New York Times article does a good job explaining the rationale behind the approach.

October 11, 2013 02:40 PM
The Cancer Genome Atlas exposes more secrets of lethal brain tumor

The Oct. 10 issue of Cell looks at the progress made by The Cancer Genome Atlas since its launch five years ago.

October 10, 2013 03:39 PM
Over the Edge for Brain Cancer Research - Media Advisory

Brain cancer survivors and VIPs to rappel down tallest building in San Diego on November 2 and 3 - all proceeds to benefit brain cancer research.

October 8, 2013 10:38 AM
Three Americans win Nobel Prize in medicine for work on traffic control system of cells

While the honorees expressed gratitude for the prize, their comments about their work were tinged with worry about the future of biomedical research after years of cuts in federal funding.

September 26, 2013 04:33 PM
Johns Hopkins Researchers Erase Human Brain Tumor Cells In Mice

The researchers caution that many treatments have cured cancers in mice and then failed in humans. But they are encouraged by the new findings and want to work quickly to design a clinical trial for humans.

September 17, 2013 01:30 PM
Brain Cancer Vaccine Gets Positive Phase 2 Results

Accelerate Brain Cancer Cure helped fund the Phase 2 trial led by Dr. Andrew Parsa, Chair of Neurosurgery at Northwestern Memorial Hospital.

August 23, 2013 12:51 PM
New Mayo Clinic Study: Avastin Boosts Survival in GBM

Researchers found that there was a “highly significant” increase in GBM patient survival in the year after Avastin was approved.

June 21, 2013 04:06 PM
Agios Files IPO To Advance Cancer Metabolism Research

Accelerate Brain Cancer Cure was an early investor in Agios to support its novel research into IDH1 gene mutation in brain cancer.   

June 18, 2013 12:08 PM
On Behalf of Patients, ABC2 Spurs Action On Avastin GBM Studies

A letter to the brain tumor community from Max Wallace, CEO of Accelerate Brain Cancer Cure.

June 13, 2013 12:18 PM
Max Wallace To Lead NCI Patient Advocate Group

This month, Max Wallace, CEO of Accelerate Brain Cancer Cure, was appointed chair of the National Cancer Institute Director's Consumer Liaison Group (DCLG). 

June 7, 2013 03:54 PM
Florida Reinstates Funding For Brain Tumor Research Center

Brain tumor research advocates, including Accelerate Brain Cancer Cure, were instrumental in the successful restoration of the program funding.

May 1, 2013 10:20 PM
Tocagen Continues To Make Progress On Its Innovative Brain Cancer Therapy

Accelerate Brain Cancer Cure was the first non-profit to fund Tocagen's virally-based drug delivery and treatment system for brain cancer.

April 15, 2013 10:39 AM
From Biotech Entrepreneur to Venture Philanthropy

Max Wallace, CEO of Accelerate Brain Cancer Cure, is a sought-after speaker at biotechnology conferences focusing on new approaches to funding treatments of the world’s most challenging diseases.


Share |

Join us in our fight for a cure!